Eltrombopag for Treatment of Thrombocytopenia Following Hematopoietic Stem Cell Transplantation

Zeynep Tuğba GüvenSerhat ÇelikBülent EserMustafa ÇetinAli ÜnalLeylagul Kaynar

Published in: Turkish journal of haematology : official journal of Turkish Society of Haematology (2022)

This real-life experience demonstrates that ELT is an effective and safe treatment option for thrombocytopenia after HSCT. The adequacy of bone marrow megakaryocytes before ELT treatment was an important factor affecting response to treatment.

Keyphrases

bone marrow
mesenchymal stem cells